Recent changes in the clinicopathologic features of Korean men with prostate cancer: A comparison with Western populations

Yonsei Medical Journal

Volumn 53, Issue 3, 2012, Pages 543-549

  Byun, Seok Soo ^a   Lee, Sangchul ^a   Lee, Sang Eun ^a   Lee, Eunsik ^b   Seo, Seong Il ^c   Lee, Hyun Moo ^c   Choi, Han Yong ^c   Song, Cheryn ^d   Ahn, Hanjong ^d   Choi, Young Deuk ^e   Cho, Jin Seon ^f  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d University of Ulsan College of Medicine   (South Korea)

^e Yonsei University College of Medicine   (South Korea)

^f Hallym University   (South Korea)

Author keywords

Ethnic groups; Prostate neoplasms; Prostatectomy; Treatment outcome

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; CANCER STAGING; CLINICAL FEATURE; ETHNIC DIFFERENCE; FOLLOW UP; GLEASON SCORE; HUMAN; HUMAN TISSUE; KOREA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PROSTATE CANCER; PROSTATECTOMY; REVIEW; TUMOR BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; HUMANS; KOREA; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84859750398     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2012.53.3.543     Document Type: Review

References (26)

1. Giovannucci E, Platz EA. Epidemiology of prostate cancer. In: Vogelzang NJ, Scardino PT, Shipley WU, Debruyne FMJ, Linehan WM, editors. Comprehensive Textbook of Genitourinary Oncology. 3rd ed. Lippincott Williams & Wilkins: Philadelphia; 2006. p.9-22.
2. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
3. Korea Statistical Information Service. [accessed on 2010 October 30]. Available at: http://www.kostat.go.kr.
4. Kim KI, Chang HJ, Cho YS, Youn TJ, Chung WY, Chae IH, et al. Current status and characteristics of hypertension control in community resident elderly Korean people: data from a Korean longitudinal study on health and aging (KLoSHa study). Hypertens Res 2008;31:97-105.
5. http://www.ncc.re.kr. Accessed March 2012.
6. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
7. Seo HK, Chung MK, Ryu SB, Lee KH; Korean Urological Oncologic Society Prostate Cancer Study Group. Detection rate of prostate cancer according to prostate-specific antigen and digital spective rectal examination in Korean men: a nationwide multicenter study. Urology 2007;70:1109-12.
8. Song C, Ro JY, Lee MS, Hong SJ, Chung BH, Choi HY, et al. Prostate cancer in Korean men exhibits poor differentiation and is adversely related to prognosis after radical prostatectomy. Urology 2006;68:820-4.
9. Epstein JI, Allsbrook WC Jr, Amin MB, Egevad LL; ISUP Grading Committee. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 2005;29:1228-42.
10. Freedland SJ, Sutter ME, Dorey F, Aronson WJ. Defining the ideal cutpoint for determining PSA recurrence after radical prostatectomy. Prostate-specific antigen. Urology 2003;61:365-9.
11. Grossfeld GD, Latini DM, Downs T, Lubeck DP, Mehta SS, Carroll PR. Is ethnicity an independent predictor of prostate cancer recurrence after radical prostatectomy? J Urol 2002;168:2510-5.
12. Freedland SJ, Amling CL, Dorey F, Kane CJ, Presti JC Jr, Terris MK, et al. Race as an outcome predictor after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Urology 2002;60:670-4.
13. Hernandez DJ, Nielsen ME, Han M, Partin AW. Contemporary evaluation of the D'amico risk classification of prostate cancer. Urology 2007;70:931-5.
14. Godley PA, Schenck AP, Amamoo MA, Schoenbach VJ, Peacock S, Manning M, et al. Racial differences in mortality among Medicare recipients after treatment for localized prostate cancer. J Natl Cancer Inst 2003;95:1702-10.
15. Haenszel W, Kurihara M. Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst 1968;40:43-68.
16. Yu H, Harris RE, Gao YT, Gao R, Wynder EL. Comparative epidemiology of cancers of the colon, rectum, prostate and breast in Shanghai, China versus the United States. Int J Epidemiol 1991; 20:76-81.
17. The Korean Urological Association. Data on statistics of management in resident training hospital in the Korean Urological Association in the year 2007. Korean J Urol 2008;49:1171-2.
18. Song C, Ahn H, Lee MS, Park J, Kwon TG, Kim HJ, et al. Mass screening for prostate cancer in Korea: a population based study. J Urol 2008;180:1949-52.
19. Cohen JH, Schoenbach VJ, Kaufman JS, Talcott JA, Schenck AP, Peacock S, et al. Racial differences in clinical progression among Medicare recipients after treatment for localized prostate cancer (United States). Cancer Causes Control 2006;17:803-11.
20. van Houten ME, Gooren LJ. Differences in reproductive endocrinology between Asian men and Caucasian men--a literature review. Asian J Androl 2000;2:13-20.
21. Wu AH, Whittemore AS, Kolonel LN, Stanczyk FZ, John EM, Gallagher RP, et al. Lifestyle determinants of 5alpha-reductase metabolites in older African-American, white, and Asian-American men. Cancer Epidemiol Biomarkers Prev 2001;10:533-8.
22. Hoffman MA, DeWolf WC, Morgentaler A. Is low serum free testosterone a marker for high grade prostate cancer? J Urol 2000; 163:824-7.
23. Hsing AW, Chu LW, Stanczyk FZ. Androgen and prostate cancer: is the hypothesis dead? Cancer Epidemiol Biomarkers Prev 2008;17:2525-30.
24. Roehl KA, Han M, Ramos CG, Antenor JA, Catalona WJ. Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results. J Urol 2004;172:910-4.
25. Schroeck FR, Aronson WJ, Presti JC Jr, Terris MK, Kane CJ, Amling CL, et al. Do nomograms predict aggressive recurrence after radical prostatectomy more accurately than biochemical recurrence alone? BJU Int 2009;103:603-8.
26. Capitanio U, Karakiewicz PI, Jeldres C, Briganti A, Gallina A, Suardi N, et al. The probability of Gleason score upgrading between biopsy and radical prostatectomy can be accurately predicted. Int J Urol 2009;16:526-9.